Strategy for rational combinations of therapeutics to target resistant human myeloma cell lines. Collaborative Agreement Celgene and Prof Andrew Spencer and Dr Tiffany Khong.
- Spencer, Andrew (Primary Chief Investigator (PCI))
- Khong, Tiffany (Chief Investigator (CI))
- Plowman, Chris, (Project Manager)
Project: Research